U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Na.O3V.4H2O
Molecular Weight 193.9906
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM METAVANADATE TETRAHYDRATE

SMILES

O.O.O.O.[Na+].[O-][V](=O)=O

InChI

InChIKey=BOTKXYOPMGFULK-UHFFFAOYSA-N
InChI=1S/Na.4H2O.3O.V/h;4*1H2;;;;/q+1;;;;;;;-1;

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O3V
Molecular Weight 98.9397
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

There is no information about pharmacological and biological application of vanadium pentoxide (V2O5). However, inhalation of this substance is a toxic for mammalian and repeated exposures to V2O5 containing particles may augment lung carcinogenesis in susceptible individuals through oxidative stress mediated pathways.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mouse. Human data not available blood-brain barrier disruption

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms.
1998 Aug
Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.
2001 Feb
Patents

Sample Use Guides

toxicity study: Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation.
Route of Administration: Respiratory
It was study to evaluate the effect of vanadium pentoxide (V2O5) on endothelial cells since they are key participants in the pathogenesis of several cardiovascular and inflammatory diseases. Cell adhesion, the expression of adhesion molecules and oxidative stress, as well as proliferation, morphology and cell death of human umbilical vein endothelial cells (HUVECs) exposed to V2O5, were evaluated. Vanadium pentoxide at a 3.12 µg cm(-2) concentration induced an enhanced adhesion of the U937 macrophage cell line to HUVECs, owing to an increased expression of late adhesion molecules. HUVECs exposed to V2O5 showed an increase in ROS and nitric oxide production, and a diminished proliferation. These changes in vanadium-treated HUVECs were accompanied by severe morphological changes and apoptotic cell death. Vanadium pentoxide induced serious endothelial cell damage, probably related to the increased cardiovascular morbidity and mortality observed in individuals living in highly air-polluted areas.
Substance Class Chemical
Created
by admin
on Sat Dec 16 00:10:40 GMT 2023
Edited
by admin
on Sat Dec 16 00:10:40 GMT 2023
Record UNII
2DO8B1WW6L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM METAVANADATE TETRAHYDRATE
MI  
Common Name English
SODIUM TRIOXOVANADATE TETRAHYDRATE
Common Name English
SODIUM VANADATE TETRAHYDRATE
Common Name English
SODIUM METAVANADATE TETRAHYDRATE [MI]
Common Name English
SODIUM VANADATE(V) TETRAHYDRATE
Common Name English
VANADIC ACID (HVO3), SODIUM SALT, TETRAHYDRATE
Systematic Name English
SODIUM VANADIUM OXIDE HYDRATE
Systematic Name English
SODIUM VANADIUM TRIOXIDE TETRAHYDRATE
Common Name English
Code System Code Type Description
PUBCHEM
23699655
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY
RXCUI
1661093
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY RxNorm
FDA UNII
2DO8B1WW6L
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY
CAS
10135-94-1
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY
DAILYMED
2DO8B1WW6L
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY
CAS
1144033-48-6
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
SUPERSEDED
DRUG BANK
DBSALT002805
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY
MERCK INDEX
m10044
Created by admin on Sat Dec 16 00:10:40 GMT 2023 , Edited by admin on Sat Dec 16 00:10:40 GMT 2023
PRIMARY Merck Index
Related Record Type Details
ANHYDROUS->SOLVATE